|
Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced that the US Patent and Trademark Office (USPTO) issued US Patent No. 11,291,628 for Welchol chewable bar, the company’s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037.
“Cosette has now obtained valuable patent protection for a novel drug delivery system that can deliver high load therapeutics, increasing patient convenience and compliance. The patent is an important aspect of Cosette’s mission of 'Innovating Every Day' and supports the continued development of our Welchol franchise,” said president and CEO of Cosette, Apurva Saraf.
Cosette Pharmaceuticals, Inc. is a US-based, fully integrated pharmaceutical company with capabilities in product development, manufacturing, and commercial operations. The current products focus on complex dosage forms including topical creams, ointments, oral liquids/solutions, suppositories, and injectables.
|